Pfizer shares rise 5% within 90 days of FDA commissioner announcement

Pfizer, a major pharma player with a broad pipeline, often benefits from regulatory easing. If the next FDA chief is perceived as industry-friendly, investors may reward Pfizer stock with a short-term rally.

Implied probability (Yes)

60%